INBX
Inhibrx, Inc. Common Stock
INBX
INBX
Delisted
INBX was delisted on the 29th of May, 2024.
100 hedge funds and large institutions have $297M invested in Inhibrx, Inc. Common Stock in 2022 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 40 increasing their positions, 25 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
46% less capital invested
Capital invested by funds: $548M → $297M (-$251M)
Holders
100
Holding in Top 10
1
Calls
$245K
Puts
$1K
Top Buyers
| 1 | +$11.6M | |
| 2 | +$10.7M | |
| 3 | +$7.93M | |
| 4 |
OM
Opaleye Management
Boston,
Massachusetts
|
+$6.7M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
+$3.45M |
Top Sellers
| 1 | -$25.7M | |
| 2 | -$12.1M | |
| 3 | -$9.06M | |
| 4 |
SI
Sofinnova Investments
Menlo Park,
California
|
-$4.16M |
| 5 |
Rafferty Asset Management
New York
|
-$2.12M |